• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮心肺支持装置救治暴发性心肌炎的长期预后

Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device.

作者信息

Maejima Yasuhiro, Yasu Takanori, Kubo Norifumi, Kawahito Koji, Omura Nobuhiro, Katsuki Takaaki, Tsukamoto Yoshiaki, Sugawara Yoshitaka, Hashimoto Shigemasa, Tsuruya Yoshio, Hirahara Taishi, Takagi Yosuke, Kobayashi Nobuhiko, Funayama Hiroshi, Ikeda Nahoko, Ishida Takeshi, Fujii Mikihisa, Ino Takashi, Saito Muneyasu

机构信息

The Division of Cardiovascular Surgery, Omiya Medical Center, Jichi Medical School, Amanuma, Omiya, Japan.

出版信息

Circ J. 2004 Sep;68(9):829-33. doi: 10.1253/circj.68.829.

DOI:10.1253/circj.68.829
PMID:15329503
Abstract

BACKGROUND

The long-term prognosis and cardiac function of fulminant myocarditis treated with percutaneous cardiopulmonary support (PCPS) was compared with the outcome of those not treated with PCPS.

METHODS AND RESULTS

From 1991 to 2000, 14 patients with fulminant myocarditis (left ventricle ejection fraction (LVEF) < or =40%) were admitted to hospital. PCPS was necessary for treatment of shock in 8 (PCPS group), but not for the remaining 6 patients (non-PCPS group). In the PCPS group, 6 patients (75%) survived the critical phase and did not have any cardiac problems after discharge (range of follow-up period, 1.4-6.0 years). All patients in the non-PCPS group survived the acute phase; 1 patient had congestive heart failure 1.5 years after discharge, and another died from malignancy (follow-up period range, 2.2-9.4 years). Although the left ventricular ejection fraction (LVEF) of the PCPS group was significantly lower than that of the non-PCPS group in the acute phase, there was no significant difference in LVEF between the 2 groups in the chronic phase.

CONCLUSION

Patients who survive the acute phase crisis of acute myocarditis have a favorable long-term survival rate, whether or not mechanical support is used.

摘要

背景

比较经皮心肺支持(PCPS)治疗暴发性心肌炎的长期预后和心功能与未接受PCPS治疗的患者的结局。

方法与结果

1991年至2000年,14例暴发性心肌炎患者(左心室射血分数[LVEF]≤40%)入院。8例患者(PCPS组)治疗休克需要PCPS,其余6例患者(非PCPS组)不需要。在PCPS组,6例患者(75%)度过危险期存活,出院后无任何心脏问题(随访期1.4 - 6.0年)。非PCPS组所有患者急性期存活;1例患者出院1.5年后出现充血性心力衰竭,另1例死于恶性肿瘤(随访期2.2 - 9.4年)。虽然急性期PCPS组的左心室射血分数(LVEF)显著低于非PCPS组,但慢性期两组之间LVEF无显著差异。

结论

急性心肌炎急性期危机存活的患者,无论是否使用机械支持,长期生存率都较好。

相似文献

1
Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device.经皮心肺支持装置救治暴发性心肌炎的长期预后
Circ J. 2004 Sep;68(9):829-33. doi: 10.1253/circj.68.829.
2
Long-term follow-up on cardiac function following fulminant myocarditis requiring percutaneous extracorporeal cardiopulmonary support.暴发性心肌炎需要经皮体外心肺支持后的心脏功能长期随访
Heart Vessels. 2013 Jan;28(1):86-90. doi: 10.1007/s00380-011-0211-8. Epub 2011 Dec 28.
3
Fulminant myocarditis treated with percutaneous cardiopulmonary support system (PCPS).采用经皮心肺支持系统(PCPS)治疗暴发性心肌炎。
Ann Thorac Cardiovasc Surg. 2008 Apr;14(2):75-80.
4
National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee).日本暴发性心肌炎全国调查:暴发性心肌炎使用经皮心肺支持的治疗指南及长期预后(科学委员会特别报告)
Circ J. 2002 Feb;66(2):133-44. doi: 10.1253/circj.66.133.
5
[Application of echocardiographic monitoring in percutaneous cardiopulmonary support for the treatment of acute fulminant myocarditis: report of one case].[超声心动图监测在经皮心肺支持治疗急性暴发性心肌炎中的应用:1例报告]
Di Yi Jun Yi Da Xue Xue Bao. 2004 May;24(5):602-3.
6
[Successful management of a man with fulminant myocarditis using percutaneous cardiopulmonary support].[经皮心肺支持成功救治一名暴发性心肌炎患者]
Masui. 2005 Feb;54(2):172-6.
7
Successful treatment of fulminant myocarditis with mechanical circulatory support.机械循环支持成功治疗暴发性心肌炎
J Card Surg. 2008 Sep-Oct;23(5):570-2. doi: 10.1111/j.1540-8191.2007.00556.x. Epub 2008 Mar 18.
8
Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.暴发性与非暴发性急性心肌炎的生存和左心室功能变化。
Circulation. 2017 Aug 8;136(6):529-545. doi: 10.1161/CIRCULATIONAHA.117.026386. Epub 2017 Jun 2.
9
Plasma concentrations of cytokines and neurohumoral factors in a case of fulminant myocarditis successfully treated with intravenous immunoglobulin and percutaneous cardiopulmonary support.
Circ J. 2004 Dec;68(12):1223-6. doi: 10.1253/circj.68.1223.
10
[Fulminant myocarditis treated with percutaneous cardiopulmonary support and long-term complications: three case reports].[经皮心肺支持治疗暴发性心肌炎及长期并发症:三例报告]
J Cardiol. 2004 Apr;43(4):185-91.

引用本文的文献

1
Venoarterial extracorporeal membrane oxygenation using magnetic levitation centrifugal pumps for fulminant myocarditis in infants, children and young adults.使用磁悬浮离心泵的静脉-动脉体外膜肺氧合治疗婴幼儿及青年暴发性心肌炎
Transl Pediatr. 2024 Dec 31;13(12):2233-2241. doi: 10.21037/tp-24-29. Epub 2024 Dec 24.
2
Early recurrence of myocarditis with atrioventricular block while wearing a wearable cardioverter-defibrillator after fulminant myocarditis: A case report.暴发性心肌炎后佩戴可穿戴式心脏复律除颤器时心肌炎合并房室传导阻滞的早期复发:一例报告
HeartRhythm Case Rep. 2023 May 4;9(7):496-500. doi: 10.1016/j.hrcr.2023.04.019. eCollection 2023 Jul.
3
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factors.
采用体外膜肺氧合治疗暴发性心肌炎患者的短期死亡率及危险因素的系统评价和荟萃分析。
Heart Fail Rev. 2023 Mar;28(2):347-357. doi: 10.1007/s10741-022-10277-z. Epub 2022 Oct 7.
4
Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study.根据急性心肌炎患者所需的经皮机械循环支持和组织学发现的预后和心功能差异:来自 CHANGE PUMP 2 研究的见解。
J Am Heart Assoc. 2022 Feb 15;11(4):e023719. doi: 10.1161/JAHA.121.023719. Epub 2022 Feb 8.
5
Effect of Acute Immunosuppression on Left Ventricular Recovery and Mortality in Fulminant Viral Myocarditis: A Case Series and Review of Literature.急性免疫抑制对暴发性病毒性心肌炎左心室恢复及死亡率的影响:病例系列及文献综述
CJC Open. 2020 Nov 11;3(3):292-302. doi: 10.1016/j.cjco.2020.10.017. eCollection 2021 Mar.
6
Extracorporeal membrane oxygenation with continuous renal replacement therapy to treat metformin-associated lactic acidosis: A case report.体外膜肺氧合联合连续性肾脏替代疗法治疗二甲双胍相关性乳酸酸中毒:一例报告
Medicine (Baltimore). 2020 Jun 26;99(26):e20990. doi: 10.1097/MD.0000000000020990.
7
KSHF Guidelines for the Management of Acute Heart Failure: Part III. Specific Management of Acute Heart Failure According to the Etiology and Co-morbidity.《急性心力衰竭管理的KSHF指南:第三部分。根据病因和合并症对急性心力衰竭进行的具体管理》
Korean Circ J. 2019 Jan;49(1):46-68. doi: 10.4070/kcj.2018.0351.
8
Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis.中华医学会心血管病学分会成人暴发性心肌炎诊断和治疗专家共识。
Sci China Life Sci. 2019 Feb;62(2):187-202. doi: 10.1007/s11427-018-9385-3. Epub 2018 Dec 3.
9
Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock due to myocarditis in adult patients.成人心肌炎所致心源性休克的静脉-动脉体外膜肺氧合治疗
J Thorac Dis. 2016 Jul;8(7):E495-502. doi: 10.21037/jtd.2016.06.26.
10
Successful treatment of near-fatal fulminant myocarditis using bi-ventricular assist device support.使用双心室辅助装置支持成功治疗近乎致命的暴发性心肌炎。
J Artif Organs. 2016 Sep;19(3):293-6. doi: 10.1007/s10047-016-0899-4. Epub 2016 Apr 6.